GILD Competitors
Gilead Sciences, Inc.
$153.54
+$5.62(+3.80%)
73
Overall
80
Value
81
Tech
60
Quality
Market Cap
$190.38B
Volume
5.73M
52W Range
$114.02 - $157.29
Target Price
$160.07
GILD competitors: AMGN, VRTX, ABBV, BIIB, ILMN. Gilead Sciences, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
GILD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $426.11 | $230.37B | $22.94 | 2.33% | 65 |
| VRTX Vertex Pharmaceuticals Incorporated | $498.50 | $122.98B | $16.65 | - | 51 |
| ABBV AbbVie Inc. | $283.48 | $500.94B | $13.94 | 2.41% | 70 |
| BIIB Biogen Inc. | $232.83 | $34.40B | $12.41 | - | 72 |
| ILMN Illumina, Inc. | $271.76 | $41.04B | $5.36 | - | 58 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $153.54 | +3.8% | 5.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |